<?xml version="1.0" encoding="UTF-8"?>
<p>One MR study opposed this evidence, finding that genetically predicted higher systolic blood pressure may decrease Alzheimer’s disease risk (
 <xref rid="fcaa031-B18" ref-type="bibr">Østergaard 
  <italic>et al.</italic>, 2015
 </xref>). A more recent MR study used SNPs associated with the expression of 12 antihypertensive drug targets and systolic blood pressure (
 <xref rid="fcaa031-B94" ref-type="bibr">Walker 
  <italic>et al.</italic>, 2019
 </xref>). Only the proxy for angiotensin-converting enzyme inhibitors was associated with Alzheimer’s disease risk.
</p>
